REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Amgen Biotechnology Singapore Pte. Ltd. (Singapore)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Amgen Biotechnology Singapore Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: research and experimental development on medical science (r&d & commercial operations on pharmaceutical & biotechnology products)

Headquarters
3 Fraser Street, #15-26/27 Duo Tower, Singapore
Singapore; Singapore; Postal Code: 189352

Contact Details: Purchase the Amgen Biotechnology Singapore Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Amgen Biotechnology Singapore Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Amgen Biotechnology Singapore Pte. Ltd. report to view the information.
Incorporation Date:
October 17, 2007
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Amgen Biotechnology Singapore Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-1.3%▼
Total operating revenue
-1.3%▼
Net Profit (Loss) for the Period
N/A
Total assets
23.27%▲
Total equity
-10.34%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo